Romero Bogado, LizSteiner, MartinaAndreu Vázquez, CristinaThuissard Vasallo, Israel JohnCobo Ibáñez, María TatianaCámara Fernández, Isabel de laEsteban Vázquez, AnaParedes Romero, María BeatrizRichi Alberti, PatriciaTrives Folguera, LauraVergara Dangond, CristinaCastañeda, ElisabetAcosta Alfaro, AnaCueva Nájera, GabrielaSánchez Díaz, RosaPuerto Muñoz, EncarnaciónMuñoz Fernández, Santiago2026-02-172026-02-172025Romero-Bogado, L., Steiner, M., Andreu-Vázquez, C., Thuissard-Vasallo, I. J., Cobo-Ibáñez, T., De La Cámara-Fernández, I., Esteban-Vázquez, A., Paredes-Romero, M. B., Richi-Alberti, P., Trives-Folguera, L., Vergara-Dangond, C., Castañeda, E., Acosta-Alfaro, A. V., Cueva-Nájera, G., Sánchez-Díaz, R., Puerto-Muñoz, E., & Muñoz-Fernández, S. (2025). Perception of COVID-19 vaccines in rheumatology patients. Medicine, 104(31), e43618. https://doi.org/10.1097/MD.00000000000436180025-79741536-5964https://hdl.handle.net/11268/16822Since the development of vaccines for coronavirus disease 2019 (COVID-19), the course of infections has changed significantly. Over the past 4 years of coexisting with the virus, a marked improvement in disease outcomes has been observed, especially in patients with rheumatological diseases; this is largely attributable to widespread immunization. This study aimed to evaluate the perception of COVID-19 vaccine protection and to describe the incidence and severity of COVID-19 in the pre- and post-vaccination periods among different patient typologies and immunosuppressive treatments in rheumatology patients. This study used observational, descriptive–analytical, ambispective, and cross-sectional methods.engAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/COVID-19Vacunas contra la COVID-19Antirreumáticosjournal article10.1097/MD.0000000000043618open accessPandemiaVacunaciónInvestigación médicaGoal 3: Ensure healthy lives and promote well-being for all at all ages